^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Maxillary Sinus Carcinoma |
| Regimen: | CAV (cyclophosphamide + pegylated liposomal doxorubicin + vincristine) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Principles of systemic therapy for non-nasopharyngeal cancers: recurrent, unresectable, or metastatic (with no surgery or RT option)…useful in certain circumstances (first- and subsequent-line)…for select ethmoid/maxillary sinus cancers…cyclophosphamide/doxorubicin/vincristine (category 2B)
